Inventor · disambiguated record
John Shiver
Also filed as: SHIVER JOHN W · SHIVER John
11 granted patents·27 pending applications·222 citations·filing 1999–2024
91Inventor score
Top patents by PatentIndex Score
38 records- 0191US6733993B2Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modificationsMERCK & CO INC·Filed 2001·Granted May 11, 2004·38 cites·57 claims
- 0289US6653125B2Synthetic hepatitis C genesMERCK & CO INC·Filed 2000·Granted Nov 25, 2003·31 cites·3 claims
- 0388US6787351B2Adenovirus carrying gag gene HIV vaccineMERCK & CO INC·Filed 2001·Granted Sep 7, 2004·23 cites·20 claims
- 0487US6534312B1Vaccines comprising synthetic genesMERCK & CO INC·Filed 1999·Granted Mar 18, 2003·74 cites·12 claims
- 0586US7598362B2Hepatitis C virus vaccineMERCK & CO INC·Filed 2002·Granted Oct 6, 2009·12 cites·50 claims
- 0685US6696291B2Synthetic HIV gag genesMERCK & CO INC·Filed 2001·Granted Feb 24, 2004·21 cites·20 claims
- 0773US7744887B2Human antibodies interacting with HIV gp41MERCK & CO INC·Filed 2005·Granted Jun 29, 2010·1 cites·11 claims
- 0872US7850973B2Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2006·Granted Dec 14, 2010·1 cites·10 claims
- 0970US8142794B2Hepatitis C virus vaccineEMINI EMILIO A·Filed 2009·Granted Mar 27, 2012·1 cites·27 claims
- 1064US2024415948A1Meningococcal b recombinant vaccineSANOFI PASTEUR INC·Filed 2024·Application pending·0 cites
- 1160US12053516B2Meningococcal B recombinant vaccineSANOFI PASTEUR INC·Filed 2022·Granted Aug 6, 2024·0 cites·15 claims
- 1257US6995008B1Coordinate in vivo gene expressionMERCK & CO INC·Filed 1999·Granted Feb 7, 2006·20 cites·12 claims
- 1355US2004180329A1Synthetic HIV gag genesFiled 2003·Application pending·0 cites
- 1455US2005070017A1Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modificationsFiled 2003·Application pending·0 cites
- 1552US2003229214A1Vaccines comprising synthetic genesFiled 2003·Application pending·0 cites
- 1652US2005074752A1Synthetic hepatitis C genesMERCK & CO INC·Filed 2003·Application pending·0 cites
- 1751US2008254059A1Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced TherebyBETT ANDREW J·Filed 2006·Application pending·0 cites
- 1851US2006148750A1Polynucleotide vaccines expressing codon optimized HIV-1 Pol and modified HIV-1 PolSHIVER JOHN W·Filed 2006·Application pending·0 cites
- 1949US2004191222A1Adenovirus serotype 34 vectors, nucleic acids and virus produced therebyFiled 2003·Application pending·0 cites
- 2049US2004101957A1Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol.nef and modificationsFiled 2001·Application pending·0 cites
- 2149US2004223976A1Influenza virus vaccineFiled 2004·Application pending·0 cites
- 2249US2004106194A1Methods for propagating adenovirus and virus produced therebyFiled 2003·Application pending·0 cites
- 2348US2003228329A1Adenovirus carrying gag gene HIV vaccineMERCK & CO INC·Filed 2003·Application pending·0 cites
- 2448US2004185555A1Adenovirus serotype 24 vectors, nucleic acids and virus produced therebyFiled 2003·Application pending·0 cites
- 2547US2010183651A1Broadly Representative Antigen Sequences and Method for SelectionFINNEFROCK ADAM C·Filed 2008·Application pending·0 cites
- 2647US2004063653A1Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 polFiled 2000·Application pending·0 cites
- 2747US2007054395A1Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modificationsEMINI EMILIO A·Filed 2006·Application pending·0 cites
- 2847US2003096778A1Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nefFiled 2000·Application pending·0 cites
- 2947US2005215508A1Polynucleotide vaccines expressing codon optimized HIV-1 Nef and modified HIV-1 NefSHIVER JOHN W·Filed 2005·Application pending·0 cites
- 3046US2005106123A1Method of inducing an enhanced immune response against hivFiled 2003·Application pending·0 cites
- 3146US2006216272A1Therapeutic immunization of hiv-infected individualsEMINI EMILIO A·Filed 2004·Application pending·0 cites
- 3245US2004087521A1Nucleic acid pharmaceuticals-influenza matrixMERCK & CO INC·Filed 2001·Application pending·0 cites
- 3344US2011052611A1Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's diseaseGARSKY VICTOR M·Filed 2010·Application pending·0 cites
- 3442US2006165664A1Method of inducing an enhanced immune response against hivEMINI EMILIO A·Filed 2003·Application pending·0 cites
- 3542US2003087225A1Synthetic HIV genesFiled 2002·Application pending·0 cites
- 3640US2007077257A1Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modificationsEMINI EMILIO A·Filed 2006·Application pending·0 cites
- 3739US2006018881A1Coordinate in vivo gene expressionLIU MARGARET A·Filed 2005·Application pending·0 cites
- 3838US2008063656A1Adenoviral Vector CompositionsEMINI EMILIO A·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Shiver files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →